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ABSTRACT Home mechanical ventilation is increasingly used by people with chronic respiratory failure.
However, there are few reports on attitudes towards treatment.
A web-based survey in eight languages was disseminated across 11 European countries to evaluate the
perception of home mechanical ventilation provision in ventilator-assisted individuals and caregivers.
Out of 787 responders from 11 European countries, 687 were patients and 100 were caregivers. 95% of
patients and 94% of caregivers were from only 4 countries (Germany, the Netherlands, Italy, Spain). The
majority of respondents were male and aged 46–65 years. Obstructive lung diseases were proportionally
more represented among respondent patients (46%), and neuromuscular diseases (65%) were more
represented among patients of respondent caregivers. About 20% of respondent patients and caregivers
were not sure of the modality of ventilation. Different interfaces were used, with a minority of respondents
in all countries using invasive home mechanical ventilation by tracheostomy.
These results may be useful for healthcare providers and policy makers to improve the quality of
patients’ daily lives.
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MECHANICAL VENTILATION
Introduction
Long-term home mechanical ventilation (HMV) is increasingly used by people with chronic respiratory
failure (CRF) arising from advanced diseases such as chronic obstructive pulmonary disease (COPD),
restrictive thoracic disease (RTD) and neuromuscular disease (NMD). The last reported (although
probably underestimated) prevalence of European patients requiring HMV is 6.6 per 100000 population [1].
More recent Canadian data report a 12.9 per 100000 prevalence [2], while other surveys report
prevalences of 9.9 and 12.0 per 100000 in Australia and New Zealand, respectively [3], and 23 per 100000
in Catalonia [4].
Although HMV has been shown to reduce patients’ symptoms, improve health-related quality of life
(HRQL) and, in many cases, reduce mortality and hospitalisations [5, 6], there are problems in providing
HMV, such as patient and caregiver compliance and training, reimbursement policies, patient/family
involvement and resources [7]. Additional factors such as the technology required and the need for
professional supervision make the management of ventilator users a difficult task. Supervision by external
companies may result in a lack of standardisation or regular feedback to the prescribing centres, as well as
increasing costs and logistical problems [8, 9]. There are also differences in end-of-life decisions between
northern and southern European countries [10]. Differences in availability, awareness, reimbursement
policies and adherence to evidence-based medical policies/indications may also lead to wide variations in
prevalence and in the patterns of HMV provision throughout different European countries [1, 8]. Few
national reports have described attitudes towards treatment in ventilator users [11–13], including patients
and caregivers, and there have been none across Europe.
A Task Force established by the European Respiratory Society (ERS) produced a statement on the
tele-monitoring of ventilator-assisted individuals [14]. To support this Task Force, a survey was
co-produced and promoted by the European Lung Foundation (ELF) to evaluate users’ perception of
HMV provision across European countries. In the present study, we report on the results on the
perception of ventilator users of 11 European countries regarding several aspects of their management.
Methods
The study was approved by the Ethical Committee of the Salvatore Maugeri Foundation (1006/2014).
The literature search was performed in the frame of the above ERS Task Force [14]. Members of the Task
Force searched EMBASE, CINALH, PubMed, PsychINFO and Scopus data bases using the following
keywords: ventilator-dependent, tele-monitoring, home mechanical ventilation, sleep disorders, respiratory
tele-medicine, tele-monitoring AND end of life. Papers published between 2003 and 2015 in English
language were considered. Members assessed the identified studies for appropriateness. Among 2975
papers, 150 were considered appropriate for analysis.
A web-based descriptive questionnaire was developed after a literature review. The online format enabled
rapid and wide-reaching dissemination of the questionnaire across Europe. The draft was reviewed by a
small working group of ventilator users to ensure the validity of the content and accessibility in terms of
language and format. The questionnaire was open online from April 14, 2014 to March 22, 2015.
Using the Eurovent survey [1] disease categories, the questionnaire was sent to HMV users with: 1) NMD:
muscular dystrophies, motor neuron disease (including amyotrophic lateral sclerosis and spinal muscular
atrophy), central hypoventilation, spinal cord damage and phrenic nerve paralysis; 2) RTD: early-onset
kyphoscoliosis, tuberculosis and lung resection sequelae; and 3) Lung and airway diseases (Lung): COPD,
cystic fibrosis, bronchiectasis, pulmonary fibrosis. Respondents who specified sleep apnoea or obesity
hypoventilation syndrome as the sole underlying cause of HMV were excluded.
The 45-item questionnaire explored four areas: 1) patients’ demographic and clinical characteristics;
2) issues influencing compliance, such as interface comfort, possibilities of travelling, sleeping and
socialising with a ventilator, type and technical functioning of the ventilator (e.g. alarms, ability to operate
and change settings, on/off switches and electricity consumption); 3) support and training and education;
and 4) requests for improved devices and support.
Caregiving was defined as follows. 1) Formal: provided by a nursing or home-care team or a personal
assistant paid by the healthcare system or patient’s insurance, etc. 2) Informal: provided by partners/
spouses and/or friends who are not professional [15, 16].
The questionnaire was available online in eight languages (English, German, Dutch, Spanish, Italian,
Portuguese, Greek and French). Full details of the aim of the questionnaire, anonymity and contact details for
the ELF were provided at the start of the questionnaire, with implied consent given by each respondent [17].
The data collected were anonymous, although respondents could choose to leave an e-mail address to
receive updates on the project. No maximum or minimum number of responses for language or country
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was set. Open responses were translated into English, and thematic analysis was conducted. The survey
was disseminated via the Task Force members, ERS and ELF professional and patient networks, and the
ELF website, newsletter and social media (Twitter and Facebook). This snowball sampling approach sought
TABLE 1 Patient demographic and home mechanical ventilation characteristics
Patients Caregivers
Responders n 687 100
Countries n
UK 16 5
Ireland 5 0
Germany 238 16
Netherlands 256 30
Portugal 5 1
Italy 97 38
Spain 65 10
Belgium 1 0
France 2 0
Czech Republic 1 0
Greece 1 0
Males 58% 44%
Age
<18 years 1% 3%
18–35 years 9% 14%
36–45 years 8% 14%
46–65 years 43% 43%
66–75 years 27% 13%
>75 years 12% 13%
Time of ventilator use
0–6 months 11% 5%
6–12 months 8% 16%
1–2 years 12% 23%
2–5 years 24% 22%
5–10 years 21% 20%
>10 years 24% 14%
Interface
Mouth mask/mouth piece 34% 30%
Nasal mask 39% 36%
Negative pressure device 0% 0%
Tracheotomy 11% 10%
Full face mask 10% 11%
Mouthpiece 4% 8%
Nasal pillows 2% 5%
Home support
Partner/spouse 29% 31%
Relative 14% 34%
Friend 3% 0%
Support worker/personal assistant 6% 12%
Nurse/home support team 14% 18%
Self/independent 19% 2%
Receiving support of two or more types 15% 3%
Time of ventilator use
Daytime 44% 65%
Night time 89% 92%
Daytime h 6 7.2
Night time h 8 9.8
Ventilation modalities
Not sure 20% 21%
Bilevel 33% 33%
Volume-cycled ventilator 7% 4%
Pressure support ventilator 8% 8%
Combination or multimode 13% 19%
Other 19% 15%
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to reach the maximum number of potential questionnaire respondents, but made it impossible to record
the number aware of the questionnaire and who chose not to respond [18]. The findings were validated by
the consistencies between the sample and the wider European HMV population, thus giving reliability and
generalisability to the findings. Preliminary and qualitative results have been summarised in an internal
ERS publication and presented at the 2016 ERS annual meeting [19, 20].
Statistical analysis
The data from the survey were recorded and summarised as percentage for dichotomous or categorical
variables. Data were analysed according to the respondents (patients and caregivers).
Results
In total, 912 individuals answered the survey, and 125 responses were excluded because they were from
non-European countries or the responses were incomplete. Out of 787 respondents from 11 European
countries, 687 were patients and 100 were caregivers. 95% of patients and 94% of caregivers were from
only 4 countries (Germany, Netherland, Italy and Spain). Patients’ demographic, geographic, ventilator
and home support characteristics, as reported by ventilator-assisted individuals (VAIs) and caregivers from
all 11 countries, are presented in table 1. The majority of respondent patients were male, and the majority
of responding caregivers’ patients were female, the majority of both being aged 46–65 years. In each of the
countries, the patients were using ventilation for an average of ⩾4 h during the day and ⩾8 h at night.
Diseases underlying the need for HMV are shown in figure 1. Lung diseases were proportionally more
represented among respondent patients (46%) whereas NMD (65%) were more represented among
patients of respondent caregivers.
Most patients used the bilevel modality and about 20% of both patients and, rather surprisingly, caregivers
were not sure about the ventilator modality (table 1). A range of interfaces were used, with oro-nasal
masks and mouthpieces being largely more represented. A minority of patients in all countries used
invasive HMV by tracheostomy (table 1). As expected, caregivers did not respond on behalf of
independent patients using their own ventilator. Relatives including partners and spouses were the primary
support for the majority of patients at home (43%) (table 1).
Technical aspects related to HMV are shown in tables 2 and 3. There were no differences between the answers
of patients and caregivers. Some aspects were highly ranked in all countries, with all aspects being identified as
important or very important. For example, the highest ranked everyday aspects were smooth “natural feeling”
breathing, being able to fall asleep and stay asleep while using the ventilator, and how comfortable the mask is.
Similarly, there was agreement on the most important technical aspects: being able to change and clean tubing
and filters and for the ventilator to respond automatically to breathing. Other issues were not considered as
important or very important by the majority of respondent patients and caregivers.
In all countries, the most common form of communicating information on ventilator use between
healthcare professional and patient was spoken information, followed by equipment demonstration and
having someone watch them use the equipment to check if they were using it correctly. Other means of
information acquisition included self-study, such as reading online and using a CD, and learning through
using the device i.e. practice. In each country, respondents had, on average, received information in more
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FIGURE 1 Diseases leading to home mechanical ventilation. RTD: restrictive thoracic disease; NMD:
neuromuscular disease.
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than one way. Issues related to satisfaction with home support, training and education are shown in table 4.
The respondents were positive about the support received at home.
Discussion
Several developments have improved the management of patients with HMV [21]. These include more
portable and easier-to-use ventilators [22], increased availability of home services, the pressure to open
intensive care unit beds to serve more unstable patients, and improved access to information and training
on HMV [10, 23]. A few reports have described the attitudes of ventilator users about their treatment
[11–13]. However, to the best of our knowledge, this is the first survey evaluating these issues in different
European countries. The information submitted in the anonymous questionnaire was considered truthful,
as there was no incentive for inaccurate reporting [15]. Furthermore, the responses are consistent with the
literature on the characteristics of HMV users in Europe [1, 8] and show good internal consistency.
In our survey, formal support was very variable among different European countries. This may reflect
differences in the organisation and resources of countries health systems. Family members are essential for
enabling patients to live at home under mechanical ventilation. Formal caregivers may include individuals
“who provide personal care or other supportive services, other than a relative or friend”. Caregiver services
range from intimate care such as dressing, bathing and feeding, to more impersonal services such as house
cleaning, meal preparation, financial management and transportation [24]. When accepting their family
member at home, informal caregivers may have a very limited understanding of their underlying diagnosis
and rate of disease progression, thereby underestimating the potential caregiver burden [25].
A higher number of caregivers were supporting a greater number of patients with NMD (figure 1) and
this was reflected in the greatest number of ventilator users for >10 years and with more respondents in
the younger age category. This is not surprising, as NMD patients are usually associated with higher levels
of dependence than those suffering from COPD. The use of long-term non-invasive ventilation (NIV) in
stable COPD patients is still under debate [5, 26]. Despite the fact that not all clinical guidelines
recommend the routine use of long-term NIV in stable COPD patients with CRF [27–30], it is common
practice in some countries, and this group accounts for approximately one-third of users in Europe [1].
Moreover, a recent international web survey among specialists dealing with NIV domiciliary programmes
examined patterns of use in these patients. Reduction in hospital admissions, improvement in HRQL and
relief of dyspnoea were considered the main expected benefits [31].
TABLE 2 Relevance of some aspects of home mechanical ventilation for patients according to respondent patients or
caregivers
Patients Caregivers Patients Caregivers
How comfortable the mask is Reducing nasal secretions
Unimportant 0% 3% Unimportant 5% 2%
Not very important 2% 1% Not very important 17% 19%
Important 19% 11% Important 30% 33%
Very important 69% 61% Very important 31% 33%
Not relevant 10% 24% Not relevant 17% 13%
How noisy the ventilator is Not feeling claustrophobic
Unimportant 5% 3% Unimportant 14% 6%
Not very important 12% 16% Not very important 14% 17%
Important 34% 36% Important 19% 21%
Very important 45% 42% Very important 30% 36%
Not relevant 4% 3% Not relevant 23% 20%
Having “natural feeling” breathing Able to speak using my ventilator
Unimportant 14% 2% Unimportant 7% 4%
Not very important 14% 6% Not very important 20% 9%
Important 19% 36% Important 30% 31%
Very important 30% 52% Very important 33% 45%
Not relevant 23% 4% Not relevant 10% 11%
How heavy the ventilator is How big the ventilator is
Unimportant 10% 18% Unimportant 8% 11%
Not very important 25% 22% Not very important 20% 31%
Important 31% 30% Important 37% 27%
Very important 26% 21% Very important 28% 25%
Not relevant 8% 9% Not relevant 7% 6%
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The most frequently identified type of ventilator for all countries was bilevel, reflecting the preference for
these ventilators as they are smaller, less expensive and easier to use than other conventional ventilators,
including volume-cycled, pressure support or combination [1, 22].
The respondents were positive about the support received at home. The Canadian survey [2] estimated a
VAI prevalence of 12.9 per 100000 population, with 73% receiving NIV. Services were delivered by 39
TABLE 3 Technical issues
Patients Caregivers Patients Caregivers
Being able to fall asleep easily and stay asleep
whilst using my ventilator
Being able to mount it on my wheelchair
Unimportant 11% 4%
Unimportant 1% 0% Not very important 8% 10%
Not very important 1% 1% Important 15% 25%
Important 21% 27% Very important 29% 41%
Very important 76% 70% Not relevant 37% 20%
Not relevant 1% 2% The ventilator responds automatically to my
breathingBeing able to travel with it (e.g. by car and air)
Unimportant 4% 8% Unimportant 2% 0%
Not very important 6% 8% Not very important 3% 3%
Important 29% 27% Important 31% 31%
Very important 53% 45% Very important 60% 62%
Not relevant 8% 12% Not relevant 4% 4%
Having alarms Being able to adjust the alarms
Unimportant 4% 3% Unimportant 7% 11%
Not very important 13% 2% Not very important 16% 12%
Important 36% 35% Important 38% 42%
Very important 42% 60% Very important 30% 33%
Not relevant 5% 0% Not relevant 9% 2%
How much electricity it uses Having an external power supply
Unimportant 17% 13% Unimportant 7% 2%
Not very important 24% 26% Not very important 15% 9%
Important 27% 36% Important 33% 23%
Very important 24% 21% Very important 34% 57%
Not relevant 8% 4% Not relevant 11% 9%
Having a built-in/integrated humidifier Having a battery with a long life
Unimportant 5% 4% Unimportant 6% 2%
Not very important 14% 8% Not very important 11% 7%
Important 33% 31% Important 32% 30%
Very important 40% 51% Very important 41% 56%
Not relevant 8% 6% Not relevant 10% 5%
The ventilator compensates for mask leaks Being able to operate the ventilator myself
(e.g. on/off buttons, alarm reset)Unimportant 3% 2%
Not very important 8% 4% Unimportant 4% 7%
Important 41% 37% Not very important 5% 6%
Very important 36% 32% Important 31% 36%
Not relevant 12% 25% Very important 53% 37%
Being able to adjust the settings Not relevant 7% 14%
Unimportant 17% 17% Having more than one pre-programmed
settingNot very important 22% 15%
Important 29% 32% Unimportant 14% 13%
Very important 19% 16% Not very important 18% 6%
Not relevant 13% 20% Important 32% 41%
Being able to clean the equipment easily Very important 22% 24%
Unimportant 1% 1% Not relevant 14% 16%
Not very important 6% 3% Being able to change/clean the tubing and
filters easilyImportant 41% 43%
Very important 50% 52% Unimportant 0% 1%
Not relevant 2% 1% Not very important 3% 2%
Important 41% 33%
Very important 55% 63%
Not relevant 1% 1%
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institutional providers and 113 community providers. Most providers stated that caregiver competency was
a prerequisite for home discharge. Important barriers to home transition were considered: insufficient
funding for paid caregivers, equipment and supplies; a shortage of paid caregivers; and negotiating public
funding arrangements. VITACCA et al. [32] evaluated factors for greater care burden. The underlying
disease, the level of dependency, hours spent under mechanical ventilation, tracheotomy, home distance
from hospital and hospital access were causes of major care burden.
Limitations of the study
This survey suffers from the limitations of any self-reported survey. The sampling approach sought to
reach the maximum number of potential questionnaire respondents, but made it impossible to record the
number aware of the questionnaire and who chose not to respond [18]. Furthermore, this online approach
prevented participation by patients without any computer/internet access. Not all patients have access to
the internet, are confident using a computer or use it regularly, or they may be too ill to fill in a survey. As
a consequence, there may be a huge selection bias.
Conclusion
With the above limitations, this survey may be useful for healthcare providers and policy makers to
improve the quality of the daily lives of VAIs. Many of the issues identified in the present article are faced
by the growing community of ventilator users.
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